Skip to main content
OpenTrials
Completed

NCT Number: NCT04634396

Possible Therapy by Phone for Caregivers

Caregivers of adults with dementia report higher stress, including anxiety and depressive symptoms, burden, and existential suffering, than caregivers of people with other chronic diseases.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Regenstrief Institute, Inc.

Indianapolis, Indiana, 46202-4800, United States

About this study

Acceptance and Commitment Therapy (ACT) is a behavioral intervention designed to increase psychological flexibility in the face of challenges. The Investigators are trying to determine proof of concept that suggests that ACT is effective in reducing anxiety and associated psychological distress in dementia caregivers. This study will recruit N=20 dementia caregivers to receive 6 weekly 1-hour telephone-based ACT sessions

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 21 years or older
  • Able to communicate in English
  • Able to provide informed consent
  • Listed as primary caregiver in the chart of a patient with Alzheimer's disease or related dementia (DARD)
  • Intends to continue caregiving form ADRD patient for at least 12 months or greater
  • Clinically elevated anxiety score (score of 10 or higher on GAD-7)

Exclusion criteria

  • Non-family member of the ADRD patient
  • Has ADRD or other serious mental illness diagnosis such as bipolar or schizophrenia as determined by ICD-10 code

Treatment and study plan

ACT Acceptance and Commitment Therapy

Behavioral

6 weeks of 1 hour sessions with a masters prepared research specialist to deliver validated tools

Primary outcomes

  1. Anxiety symptoms measured by the Generalized Anxiety Disorder Scale (GAD-7)

    Time frame: through study completion, an average of 6 months

    Anxiety will be measured using the GAD-7 which contains 7 items with total scores ranging from 0 to 21. Scores of 5, 10 and 15 are cut off scores for mild, moderate and severe anxiety respectively. An add-on item assessing the patient's global impression of symptom related impairment helps researchers understand the extent to which anxiety interferes in daily life. The GAD-7 has factorial validity for the diagnosis of general anxiety disorder and is sensitive to change

Secondary outcomes

  1. Depressive symptoms measured by the Patient Health Questionnarie-9 (PHQ-9)

    Time frame: through study completion, an average of 6 months

    Depressive symptoms will be measured using the 9 item Patient Health Questionnaire-9 (PHQ-9) to assess depressive symptoms. With total scores ranging from 0-27. scores of 5, 10, 15 and 20 represent mild, moderate, moderately severe and severe depression, respectively. The PHQ-9 has factorial validity for the diagnosis of major depressive disorder

  2. Caregiver burden measured by the Zarit Burden Interview (ZBI)

    Time frame: through study completion, an average of 6 months

    Caregiver burden will be measured using the ZARIT Burden Interview (ZBI). This two

    factor 22 item scale measures personal strain and role strain in caregiving by summing

    responses to a total score (0-20) little or no burden; 21-40 mild to moderate burden; 41-60

    moderate to severe burden; and 61-88; severe burden). The ZBI measures change over time resulting from the progression of the patient's symptoms or from interventions aimed at reducing burden

  3. Physical, emotional and existential suffering to caregivers measured by the Experience of Suffering Scale (ESS)

    Time frame: through study completion, an average of 6 months

    Well being will be measured using the (ESS). With prior testing in ADRD caregivers, the ESS contains 33 items across 3 subscales: physical (9items), psychological (15 items), and existential (9 items) suffering. Total scores for each subscale are calculated with higher scores indicating more suffering within each domain

  4. Different strategies that caregivers use to cope measured with the Brief COPE

    Time frame: through study completion, an average of 6 months

    Coping will be measured with the 28 item Brief COPE. A measure of coping strategies used in response to stressors. Comprised of 28 coping strategies, the Brief COPE contains 14 two item subscales, each analyzed separately; self distraction, active coping, denial, substance use, use of emotional support, use of instrumental support, venting, behavioral disengagement, positive reframing, planning, humor, acceptance, religion and self-blame

  5. Caregivers psychological flexibility measured by the Acceptance and Action Questionnaire-II (AAQ-II)

    Time frame: through study completion, an average of 6 months

    Psychological flexibility and its opposite, experiential avoidance will be measured using the 7 item Acceptance and Action Questionnaire-II (AAQ-II). Respondents rate how true each statement (e,g it is okay if I remember something unpleasant) is for them on a 7 point Likert type scale anchored from 1=never true to 7- always true. Higher scores indicate greater psychological flexibility or acceptance

  6. Overall quality of life will be measured with the NIH PROMIS Global Health measure

    Time frame: through study completion, an average of 6 months

    Quality of Life will be assessed with the 10-item PROMIS Global Health measure. On a 5-point scale, participants rate their mental and physical well-being with higher scores indicative of better health

  7. Caregivers grief during active caregiving will be measured with the Anticipatory Grief Scale (AGS)

    Time frame: through study completion, an average of 6 months

    Anticipatory grief will be measured by the AGS, a 27 item self report tool designed to assess the bereavement experience of dementia caregivers. Items are scored on a 5-point Likert type scale with responses ranging from "strongly disagree" to "strongly agree".

Other outcomes

  1. The feasibility of the TACTICs Intervention will be measured by accrual rate, attendance of sessions, and the retention in the study

    Time frame: baseline and through study completion, an average of 6 months.

    The investigators will assess the number of eligibly screened caregivers who choose to consent and enroll in the pilot study, assess the total number of sessions that participants attend the number of enrolled subjects completing the outcome assessments.

  2. Caregivers acceptability of the TACTICs intervention

    Time frame: through study completion, an average of 6 months

    The investigators will assess intervention acceptability using a brief investigator created battery of qualitative and quantitative satisfaction items

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Collaborators

  • Regenstrief Institute, Inc.

Registry information

Official study title

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Alzheimer's Disease and Related Dementias. A Single Arm Pilot

Acronym: TACTICs

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Nov 18, 2020
Registry last updated
Mar 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.